Table 5.
NLR.
| Men | Pre-M | Pre-MPP | Post-M | |
|---|---|---|---|---|
| Recent NLR | 1.3 ± 0.2∗ | 1.8 ± 0.2 | 3.2 ± 0.5 (8)∗ | 1.9 ± 0.3 |
| > (3.4 ± 0.2) | — | 23.1% | 62.5% | 18.2% |
| < (1.5 ± 0.1) | 100.0% | 76.9% | 37.5% | 81.8% |
| NLR at diagnosis | 1.7 ± 0.3∗ | 1.7 ± 0.2∗ | 2.7 ± 0.3∗ | 2.7 ± 0.3∗ |
| > at diagnosis (3.0 ± 0.1) | 25.0% | 23.1% | 66.6% | 63.6% |
| < at diagnosis (1.6 ± 0.1) | 75.0% | 76.9% | 33.3% | 36.4% |
| ΔNLR | −0.4 ± 0.2 | −0.2 ± 0.2 | 0.3 ± 0.5 | −0.7 ± 0.4 |
| NLR-I (0.7 ± 0.2) | 25.0% | 38.5% | 50.0% | 27.3% |
| NLR-D (−0.8 ± 0.1) | 75.0% | 61.5% | 50.0% | 72.7% |
NLR: neutrophil-to-lymphocyte ratio; ΔNLR: delta NLR after GFD versus NLR before GFD; D: decrease; I: increase. < below cut off and > over cut off 2.32; Pre-M: premenopausal; Pre-MPP: premenopausal previous pregnancy; Post-M: postmenopausal. Data are expressed as mean ± SEM or percentages. ∗p < 0.05.